单位(元)易方达生物科技指数分级A(150257)利润表 |
报告期 |
2020/12/2 |
2020/6/30 |
2019/12/31 |
2019/6/30 |
收入 |
11,680,078 |
98,449,822 |
80,102,944 |
53,001,138 |
利息收入 |
123,098 |
42,085 |
77,970 |
40,841 |
其中:存款利息收入 |
122,995 |
42,041 |
77,940 |
40,841 |
债券利息收入 |
104 |
44 |
29 |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益 |
28,143,736 |
15,377,263 |
-5,376,670 |
-11,415,308 |
其中:股票投资收益 |
27,118,895 |
14,794,724 |
-6,512,913 |
-12,266,716 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
131,650 |
63,969 |
12,204 |
- |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
893,191 |
518,570 |
1,124,039 |
851,408 |
公允价值变动收益 |
-17,440,061 |
82,961,823 |
85,292,542 |
64,299,606 |
汇兑收益 |
- |
- |
- |
- |
其他收入 |
853,305 |
68,651 |
109,102 |
75,999 |
费用 |
5,507,465 |
1,487,784 |
2,833,167 |
1,461,474 |
管理人报酬 |
3,263,551 |
917,858 |
1,740,218 |
866,517 |
托管费 |
717,981 |
201,929 |
382,848 |
190,634 |
销售服务费 |
- |
- |
- |
- |
交易费用 |
1,086,554 |
155,178 |
264,643 |
173,829 |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
439,378 |
212,820 |
445,458 |
230,495 |
利润总额 |
6,172,613 |
96,962,038 |
77,269,777 |
51,539,664 |
减:所得税费用 |
- |
- |
- |
- |
净利润 |
6,172,613 |
96,962,038 |
77,269,777 |
51,539,664 |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。